{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:39:26Z","timestamp":1790433566732,"version":"4.1.0"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL007260"],"award-info":[{"award-number":["T32HL007260"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DK083262"],"award-info":[{"award-number":["T32DK083262"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DE017551"],"award-info":[{"award-number":["T32DE017551"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0207844","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T19:07:51Z","timestamp":1545419271000},"page":"e0207844","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Suppression of angiotensin II-induced pathological changes in heart and kidney by the caveolin-1 scaffolding domain peptide"],"prefix":"10.1371","volume":"13","author":[{"given":"Panneerselvam","family":"Chinnakkannu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Antony","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraswathi","family":"Panneerselvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorea","family":"Pleasant-Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupak","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalin","family":"Baicu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tourkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7948-038X","authenticated-orcid":true,"given":"Dhandapani","family":"Kuppuswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"281240","DOI":"10.4061\/2011\/281240","article-title":"Vascular inflammation and endothelial dysfunction in experimental hypertension","volume":"2011","author":"C Savoia","year":"2011","journal-title":"Int J Hypertens"},{"issue":"3 Pt 2","key":"ref2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/hy09t1.094234","article-title":"Angiotensin II and renal fibrosis","volume":"38","author":"SA Mezzano","year":"2001","journal-title":"Hypertension"},{"issue":"2","key":"ref3","first-page":"158","article-title":"Aging and Cardiac Fibrosis","volume":"2","author":"A Biernacka","year":"2011","journal-title":"Aging Dis"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta1 and angiotensin networking in cardiac remodeling","volume":"63","author":"S Rosenkranz","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.yjmcc.2010.05.005","article-title":"Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy","volume":"49","author":"SB Haudek","year":"2010","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0025-7125(03)00125-1","article-title":"Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system","volume":"88","author":"A Gonzalez","year":"2004","journal-title":"Med Clin North Am"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11886-009-0061-5","article-title":"Hypertension and diastolic heart failure","volume":"11","author":"AH Gradman","year":"2009","journal-title":"Curr Cardiol Rep"},{"issue":"14","key":"ref8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"MR Zile","year":"2015","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","article-title":"The cardiac fibroblast: therapeutic target in myocardial remodeling and failure","volume":"45","author":"RD Brown","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"RT Kendall","year":"2014","journal-title":"Front Pharmacol"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"H2924","DOI":"10.1152\/ajpheart.00153.2006","article-title":"Cardiac myofibroblasts differentiated in 3D culture exhibit distinct changes in collagen I production, processing, and matrix deposition","volume":"291","author":"F Poobalarahi","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.12.031","article-title":"Origins of cardiac fibroblasts","volume":"91","author":"T Moore-Morris","year":"2016","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCRESAHA.115.303794","article-title":"Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation","volume":"115","author":"SR Ali","year":"2014","journal-title":"Circ Res"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"T Moore-Morris","year":"2014","journal-title":"J Clin Invest"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1369\/0022155413493912","article-title":"Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction","volume":"61","author":"P Christia","year":"2013","journal-title":"J Histochem Cytochem"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1160\/TH08-11-0726","article-title":"The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders","volume":"101","author":"EC Keeley","year":"2009","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"e7475","DOI":"10.1371\/journal.pone.0007475","article-title":"Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts","volume":"4","author":"D Pilling","year":"2009","journal-title":"PLoS One"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.exphem.2010.03.004","article-title":"Fibrocytes in health and disease","volume":"38","author":"EL Herzog","year":"2010","journal-title":"Exp Hematol"},{"key":"ref19","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","author":"L Wang","year":"2018","journal-title":"Eur Heart J"},{"issue":"48","key":"ref20","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.1073\/pnas.0608799103","article-title":"Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice","volume":"103","author":"SB Haudek","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/path.2281","article-title":"Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction","volume":"214","author":"MJ van Amerongen","year":"2008","journal-title":"J Pathol"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jcp.22322","article-title":"The origin of fibroblasts and mechanism of cardiac fibrosis","volume":"225","author":"G Krenning","year":"2010","journal-title":"J Cell Physiol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"H538","DOI":"10.1152\/ajpheart.01114.2010","article-title":"CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis","volume":"301","author":"J Xu","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1097\/HJH.0b013e32835639bb","article-title":"Elevated circulating fibrocyte levels in patients with hypertensive heart disease","volume":"30","author":"EC Keeley","year":"2012","journal-title":"J Hypertens"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1096\/fj.14-268136","article-title":"Mesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart","volume":"29","author":"KA Cieslik","year":"2015","journal-title":"FASEB J"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2353\/ajpath.2010.090574","article-title":"Bone marrow-derived cells contribute to fibrosis in the chronically failing heart","volume":"176","author":"PY Chu","year":"2010","journal-title":"Am J Pathol"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"EM Zeisberg","year":"2007","journal-title":"Nat Med"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac Fibrosis: The Fibroblast Awakens","volume":"118","author":"JG Travers","year":"2016","journal-title":"Circ Res"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"e0131731","DOI":"10.1371\/journal.pone.0131731","article-title":"Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in Mice","volume":"10","author":"T Honjo","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/MB:24:1:27","article-title":"Historical perspective of the renin-angiotensin system","volume":"24","author":"JE Hall","year":"2003","journal-title":"Mol Biotechnol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11906-014-0420-5","article-title":"ACE2: angiotensin II\/angiotensin-(1\u20137) balance in cardiac and renal injury","volume":"16","author":"J Varagic","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13069-015-0023-z","article-title":"Modulation of angiotensin II signaling in the prevention of fibrosis","volume":"8","author":"AM Murphy","year":"2015","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"C457","DOI":"10.1152\/ajpcell.00380.2002","article-title":"Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42\/44 MAP kinase in cardiac fibroblasts","volume":"284","author":"AW Cohen","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/art.23791","article-title":"Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis","volume":"58","author":"F Del Galdo","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/ard.2009.117580","article-title":"Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease","volume":"69","author":"E Tourkina","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref36","first-page":"140","article-title":"Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis","volume":"5","author":"R Lee","year":"2014","journal-title":"Front Pharmacol"},{"issue":"5\u20136","key":"ref37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.matbio.2011.05.003","article-title":"Caveolin-1 modulates TGF-beta1 signaling in cardiac remodeling","volume":"30","author":"SK Miyasato","year":"2011","journal-title":"Matrix Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2014.07.020","article-title":"Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction","volume":"76","author":"P Shivshankar","year":"2014","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/art.38572","article-title":"Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease","volume":"66","author":"C Reese","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13069-015-0028-7","article-title":"Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1","volume":"8","author":"R Lee","year":"2015","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"L843","DOI":"10.1152\/ajplung.00295.2007","article-title":"Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo","volume":"294","author":"E Tourkina","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1165\/rcmb.2011-0349OC","article-title":"Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice","volume":"47","author":"P Shivshankar","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/labinvest.2016.153","article-title":"Reversal of maladaptive fibrosis and compromised ventricular function in the pressure overloaded heart by a caveolin-1 surrogate peptide","volume":"97","author":"D Pleasant-Jenkins","year":"2017","journal-title":"Lab Invest"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"e0140273","DOI":"10.1371\/journal.pone.0140273","article-title":"Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction Model","volume":"10","author":"S Balasubramanian","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"e45076","DOI":"10.1371\/journal.pone.0045076","article-title":"beta3 integrin in cardiac fibroblast is critical for extracellular matrix accumulation during pressure overload hypertrophy in mouse","volume":"7","author":"S Balasubramanian","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/FJC.0b013e3181d9f5d4","article-title":"Lack of beta3 integrin signaling contributes to calpain-mediated myocardial cell loss in pressure-overloaded myocardium","volume":"55","author":"G Suryakumar","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1096\/fj.08-127480","article-title":"Beta3 integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy","volume":"23","author":"RK Johnston","year":"2009","journal-title":"FASEB J"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-4-15","article-title":"Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide","volume":"4","author":"E Tourkina","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0008-6363(00)00044-4","article-title":"Angiotensin II, adhesion, and cardiac fibrosis","volume":"46","author":"JM Schnee","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"A Leask","year":"2010","journal-title":"Circ Res"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCRESAHA.107.160077","article-title":"Targeting the calpain\/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension","volume":"102","author":"E Letavernier","year":"2008","journal-title":"Circ Res"},{"issue":"14","key":"ref52","doi-asserted-by":"crossref","first-page":"13879","DOI":"10.1074\/jbc.M412551200","article-title":"Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK\/ERK and caveolin-1 signaling","volume":"280","author":"E Tourkina","year":"2005","journal-title":"J Biol Chem"},{"key":"ref53","article-title":"Hypertension-induced cognitive impairment: insights from prolonged angiotensin II infusion in mice","author":"S Foulquier","year":"2018","journal-title":"Hypertens Res"},{"issue":"3","key":"ref54","first-page":"307","article-title":"Coronary vascular hyperpermeability and angiotensin II","volume":"126","author":"HK Reddy","year":"1995","journal-title":"J Lab Clin Med"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semnephrol.2004.04.008","article-title":"Nitric oxide, angiotensin II, and hypertension","volume":"24","author":"MS Zhou","year":"2004","journal-title":"Semin Nephrol"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/HYPERTENSIONAHA.115.06004","article-title":"Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin alphaVbeta3\/nuclear factor-kappaB\/interleukin-6 axis","volume":"66","author":"N Shimojo","year":"2015","journal-title":"Hypertension"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"44911","DOI":"10.1038\/srep44911","article-title":"Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)","volume":"7","author":"Z Xu","year":"2017","journal-title":"Sci Rep"},{"issue":"13","key":"ref58","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1084\/jem.20061536","article-title":"Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis","volume":"203","author":"XM Wang","year":"2006","journal-title":"J Exp Med"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1582-4934.2010.01063.x","article-title":"Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5","volume":"15","author":"Y Yamaguchi","year":"2011","journal-title":"J Cell Mol Med"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/01.HYP.35.4.978","article-title":"Angiotensin II and alpha(v)beta(3) integrin expression in rat neonatal cardiac fibroblasts","volume":"35","author":"K Graf","year":"2000","journal-title":"Hypertension"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s004180050200","article-title":"Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis","volume":"109","author":"M Kasper","year":"1998","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2008.11.003","article-title":"NADPH oxidases and angiotensin II receptor signaling","volume":"302","author":"AM Garrido","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/HYPERTENSIONAHA.116.08278","article-title":"Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II","volume":"69","author":"SJ Forrester","year":"2017","journal-title":"Hypertension"},{"issue":"2","key":"ref64","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/j.gastro.2008.10.085","article-title":"Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis","volume":"136","author":"JH Chidlow Jr.","year":"2009","journal-title":"Gastroenterology"},{"issue":"23","key":"ref65","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.4161\/cbt.8.23.10138","article-title":"Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells","volume":"8","author":"SA Tahir","year":"2009","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1535-6108(03)00168-5","article-title":"Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice","volume":"4","author":"JP Gratton","year":"2003","journal-title":"Cancer Cell"},{"issue":"22","key":"ref67","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.jacc.2010.12.032","article-title":"Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling","volume":"57","author":"YT Horikawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"ref68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0962-8924(94)90114-7","article-title":"Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis","volume":"4","author":"MP Lisanti","year":"1994","journal-title":"Trends Cell Biol"},{"issue":"8","key":"ref69","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbamcr.2010.03.015","article-title":"Differential involvement of caveolin-1 in brown adipocyte signaling: impaired beta3-adrenergic, but unaffected LPA, PDGF and EGF receptor signaling","volume":"1803","author":"CL Mattsson","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"ref70","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/CIRCRESAHA.107.160978","article-title":"Targeting focal adhesion kinase with small interfering RNA prevents and reverses load-induced cardiac hypertrophy in mice","volume":"101","author":"CF Clemente","year":"2007","journal-title":"Circ Res"},{"issue":"8","key":"ref71","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00109-012-0883-2","article-title":"Disruption of mindin exacerbates cardiac hypertrophy and fibrosis","volume":"90","author":"ZY Bian","year":"2012","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"ref72","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/HYPERTENSIONAHA.115.05627","article-title":"Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction","volume":"66","author":"H Peng","year":"2015","journal-title":"Hypertension"},{"issue":"7","key":"ref73","doi-asserted-by":"crossref","first-page":"e70195","DOI":"10.1371\/journal.pone.0070195","article-title":"Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension","volume":"8","author":"LH Wei","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"ref74","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/gtc.12055","article-title":"Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16","volume":"18","author":"E Matsumoto","year":"2013","journal-title":"Genes Cells"},{"issue":"5","key":"ref75","doi-asserted-by":"crossref","first-page":"H771","DOI":"10.1152\/ajpheart.00282.2015","article-title":"A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II","volume":"309","author":"JA Regan","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"ref76","doi-asserted-by":"crossref","first-page":"F949","DOI":"10.1152\/ajprenal.00199.2014","article-title":"Role of caveolin 1 in AT1a receptor-mediated uptake of angiotensin II in the proximal tubule of the kidney","volume":"307","author":"XC Li","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"13","key":"ref77","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1084\/jem.20090449","article-title":"Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase","volume":"206","author":"AE Loot","year":"2009","journal-title":"J Exp Med"},{"issue":"3","key":"ref78","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00395-008-0754-8","article-title":"Aging-associated insulin resistance predisposes to hypertension and its reversal by exercise: the role of vascular vasorelaxation to insulin","volume":"104","author":"QX Li","year":"2009","journal-title":"Basic Res Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0207844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:22:00Z","timestamp":1589001720000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0207844"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":78,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0207844","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]}}}